Ming Zhu

611 total citations
33 papers, 486 citations indexed

About

Ming Zhu is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Ming Zhu has authored 33 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Biomaterials and 6 papers in Biomedical Engineering. Recurrent topics in Ming Zhu's work include Nanoparticle-Based Drug Delivery (10 papers), RNA Interference and Gene Delivery (3 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Ming Zhu is often cited by papers focused on Nanoparticle-Based Drug Delivery (10 papers), RNA Interference and Gene Delivery (3 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Ming Zhu collaborates with scholars based in China, South Korea and United States. Ming Zhu's co-authors include Chang Deok Kim, Jeung‐Hoon Lee, Jingyuan Wang, Xuesi Chen, Yapeng Li, Yulei Chang, Kun Li, Yili Zhao, Xinlei Meng and G Frenkel and has published in prestigious journals such as Journal of Colloid and Interface Science, Journal of Membrane Science and Experimental Cell Research.

In The Last Decade

Ming Zhu

31 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ming Zhu China	14	194	137	125	85	79	33	486
Xiumei Zhu China	13	240 1.2×	169 1.2×	97 0.8×	102 1.2×	56 0.7×	20	525
Chengming Zhou China	12	183 0.9×	198 1.4×	120 1.0×	38 0.4×	36 0.5×	21	501
Roun Heo South Korea	11	282 1.5×	226 1.6×	181 1.4×	49 0.6×	42 0.5×	14	637
Lucien Bildstein France	7	208 1.1×	215 1.6×	156 1.2×	67 0.8×	49 0.6×	8	462
Aida Varela-Moreira Netherlands	12	202 1.0×	274 2.0×	149 1.2×	65 0.8×	38 0.5×	16	507
Suo-Qin Tang China	12	295 1.5×	241 1.8×	208 1.7×	91 1.1×	36 0.5×	41	570
Jiajing Tang China	14	229 1.2×	152 1.1×	213 1.7×	46 0.5×	31 0.4×	39	514
Dina Polyak Israel	11	300 1.5×	313 2.3×	216 1.7×	130 1.5×	75 0.9×	21	681
Zhen Ding China	13	130 0.7×	137 1.0×	161 1.3×	33 0.4×	23 0.3×	28	579
Juan Fan China	18	231 1.2×	245 1.8×	156 1.2×	127 1.5×	36 0.5×	38	785

Countries citing papers authored by Ming Zhu

Since Specialization

Citations

This map shows the geographic impact of Ming Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Zhu more than expected).

Fields of papers citing papers by Ming Zhu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Zhu. The network helps show where Ming Zhu may publish in the future.

Co-authorship network of co-authors of Ming Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Zhu. A scholar is included among the top collaborators of Ming Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Zhu. Ming Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shen, Wenming, et al.. (2025). NSUN3 Aggravates Sepsis‐Associated Acute Kidney Injury by Stabilising TIFA mRNA Through m5C. Clinical and Experimental Pharmacology and Physiology. 52(4). e70026–e70026. 3 indexed citations

Tang, Huan, Zheng Zhang, Ming Zhu, et al.. (2023). Efficient Delivery of Gemcitabine by Estrogen Receptor-Targeted PEGylated Liposome and Its Anti-Lung Cancer Activity In Vivo and In Vitro. Pharmaceutics. 15(3). 988–988. 11 indexed citations

Lv, Zhe, Han Bao, Ming Zhu, et al.. (2023). A novel deformable liposomal hydrogel loaded with a SREBP-1-inhibiting polypeptide for reducing sebum synthesis in golden hamster model. European Journal of Pharmaceutical Sciences. 187. 106483–106483. 1 indexed citations

Zhu, Ming, Huan Tang, Zeng Wang, et al.. (2022). Estrone-targeted PEGylated Liposomal Nanoparticles for Cisplatin (DDP) Delivery in Cervical Cancer. European Journal of Pharmaceutical Sciences. 174. 106187–106187. 15 indexed citations

Sun, Yuxin, Huan Tang, Zhihui Ren, et al.. (2021). In vitro and in vivo Evaluation of a Novel Estrogen-Targeted PEGylated Oxaliplatin Liposome for Gastric Cancer. International Journal of Nanomedicine. Volume 16. 8279–8303. 29 indexed citations

Li, Xue Mei, et al.. (2019). Inhibition of Insulin-Like Growth Factor-1–Induced Sebum Production by Bilobetin in Cultured Human Sebocytes. Annals of Dermatology. 31(3). 294–294. 8 indexed citations

Zhang, Qingling, et al.. (2019). Inhibition of Poly(I:C)-Induced Inflammation by Salvianolic Acid A in Skin Keratinocytes. Annals of Dermatology. 31(3). 279–279. 5 indexed citations

Zhang, Qingling, et al.. (2019). Tumor Suppressive Function of NQO1 in Cutaneous Squamous Cell Carcinoma (SCC) Cells. BioMed Research International. 2019. 1–9. 21 indexed citations

Yu, Xin, Xiangsheng Wang, Ming Zhu, et al.. (2017). Expansion of CD26 positive fibroblast population promotes keloid progression. Experimental Cell Research. 356(1). 104–113. 36 indexed citations

10.

Zhou, Mingwei, et al.. (2016). Inhibition of collagen synthesis by IWR-1 in normal and keloid-derived skin fibroblasts. Life Sciences. 173. 86–93. 13 indexed citations

11.

Wei, Wei, Xigui Yue, Zhou Yang, et al.. (2014). Novel ternary Fe3O4@polyaniline/polyazomethine/polyetheretherketone crosslinked hybrid membranes: fabrication, thermal properties and electromagnetic behaviours. RSC Advances. 4(22). 11159–11159. 17 indexed citations

12.

Liu, Yongping, et al.. (2014). Trastuzumab increases the sensitivity of HER2-amplified human gastric cancer cells to oxaliplatin and cisplatin by affecting the expression of telomere-associated proteins. Oncology Letters. 9(2). 999–1005. 12 indexed citations

13.

Chen, Peng, Yapeng Li, Shuwei Wang, et al.. (2013). Chemoenzymatic Synthesis of Dual-responsive Amphiphilic Block Copolymers and Drug Release Studies. Bulletin of the Korean Chemical Society. 34(6). 1800–1808.

14.

Chang, Yulei, Xinlei Meng, Yili Zhao, et al.. (2011). Novel water-soluble and pH-responsive anticancer drug nanocarriers: Doxorubicin–PAMAM dendrimer conjugates attached to superparamagnetic iron oxide nanoparticles (IONPs). Journal of Colloid and Interface Science. 363(1). 403–409. 88 indexed citations

15.

Piao, Yongjun, Ming Zhu, Jin‐Man Kim, et al.. (2005). Involvement of urokinase‐type plasminogen activator in sphingosylphosphorylcholine‐induced angiogenesis. Experimental Dermatology. 14(5). 356–362. 16 indexed citations

16.

Zhu, Ming, Chang Deok Kim, Woonghee Lee, et al.. (2005). Induction of connective tissue growth factor expression by sphingosylphosphorylcholine in cultured human skin fibroblasts. Experimental Dermatology. 14(7). 509–514. 15 indexed citations

17.

Caffrey, Paula B., et al.. (1999). Rapid development of glutathione-S-transferase-dependent drug resistance in vitro and its prevention by ethacrynic acid. Cancer Letters. 136(1). 47–52. 13 indexed citations

18.

Zhu, Ming, et al.. (1998). Studies on the mechanism of the selenite-induced decrease in cell attachment. Biological Trace Element Research. 62(3). 123–134. 5 indexed citations

19.

Caffrey, Paula B., Ming Zhu, & G Frenkel. (1998). Prevention of the development of melphalan resistance in vitro by selenite. Biological Trace Element Research. 65(3). 187–195. 8 indexed citations

20.

Duan, Li, et al.. (1988). [Absorption, distribution and excretion of gallanilide in rats and bioavailability in rabbits].. PubMed. 9(2). 182–5.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact